Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Glaucoma is an asymptomatic eye-related disorder that occurs due to the buildup of fluid pressure inside the eye. This leads to damage of the optic nerve in the eye, and is a hereditary disorder. Immediate treatment of people suffering from glaucoma is essential as glaucoma in severe cases may result in loss of vision permanently. In addition, glaucoma is anticipated to be the leading cause of blindness among people in the age group of 60 years and above. The glaucoma surgeries comprise of non-invasive devices, invasive as well as minimally invasive devices to decrease the production of intraocular fluid, which is also known as aqueous humor.
The global Glaucoma market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The key factors that drive the market growth include increase in prevalence of glaucoma disease worldwide and growth in geriatric population. In addition, rise in demand for advanced ophthalmic devices supplement the market growth.
This report aims to provide a comprehensive presentation of the global market for Glaucoma, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glaucoma.
Report Scope
The Glaucoma market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Glaucoma market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Glaucoma companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Segment by Type
Segment by Application
By Region
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Glaucoma companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Glaucoma Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Conventional Glaucoma Surgeries
1.2.3 Minimally Invasive Glaucoma Surgeries
1.3 Market by Application
1.3.1 Global Glaucoma Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Eye Hospitals
1.3.3 Ophthalmology Clinics
1.3.4 Outpatient Surgical Centers
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Glaucoma Market Perspective (2019-2030)
2.2 Glaucoma Growth Trends by Region
2.2.1 Global Glaucoma Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Glaucoma Historic Market Size by Region (2019-2024)
2.2.3 Glaucoma Forecasted Market Size by Region (2025-2030)
2.3 Glaucoma Market Dynamics
2.3.1 Glaucoma Industry Trends
2.3.2 Glaucoma Market Drivers
2.3.3 Glaucoma Market Challenges
2.3.4 Glaucoma Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Glaucoma Players by Revenue
3.1.1 Global Top Glaucoma Players by Revenue (2019-2024)
3.1.2 Global Glaucoma Revenue Market Share by Players (2019-2024)
3.2 Global Glaucoma Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Glaucoma Revenue
3.4 Global Glaucoma Market Concentration Ratio
3.4.1 Global Glaucoma Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Glaucoma Revenue in 2023
3.5 Glaucoma Key Players Head office and Area Served
3.6 Key Players Glaucoma Product Solution and Service
3.7 Date of Enter into Glaucoma Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Glaucoma Breakdown Data by Type
4.1 Global Glaucoma Historic Market Size by Type (2019-2024)
4.2 Global Glaucoma Forecasted Market Size by Type (2025-2030)
5 Glaucoma Breakdown Data by Application
5.1 Global Glaucoma Historic Market Size by Application (2019-2024)
5.2 Global Glaucoma Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Glaucoma Market Size (2019-2030)
6.2 North America Glaucoma Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Glaucoma Market Size by Country (2019-2024)
6.4 North America Glaucoma Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Glaucoma Market Size (2019-2030)
7.2 Europe Glaucoma Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Glaucoma Market Size by Country (2019-2024)
7.4 Europe Glaucoma Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Glaucoma Market Size (2019-2030)
8.2 Asia-Pacific Glaucoma Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Glaucoma Market Size by Region (2019-2024)
8.4 Asia-Pacific Glaucoma Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Glaucoma Market Size (2019-2030)
9.2 Latin America Glaucoma Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Glaucoma Market Size by Country (2019-2024)
9.4 Latin America Glaucoma Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Glaucoma Market Size (2019-2030)
10.2 Middle East & Africa Glaucoma Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Glaucoma Market Size by Country (2019-2024)
10.4 Middle East & Africa Glaucoma Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Detail
11.1.2 Novartis Business Overview
11.1.3 Novartis Glaucoma Introduction
11.1.4 Novartis Revenue in Glaucoma Business (2019-2024)
11.1.5 Novartis Recent Development
11.2 Glaukos
11.2.1 Glaukos Company Detail
11.2.2 Glaukos Business Overview
11.2.3 Glaukos Glaucoma Introduction
11.2.4 Glaukos Revenue in Glaucoma Business (2019-2024)
11.2.5 Glaukos Recent Development
11.3 New World Medical
11.3.1 New World Medical Company Detail
11.3.2 New World Medical Business Overview
11.3.3 New World Medical Glaucoma Introduction
11.3.4 New World Medical Revenue in Glaucoma Business (2019-2024)
11.3.5 New World Medical Recent Development
11.4 Ellex Medical Lasers
11.4.1 Ellex Medical Lasers Company Detail
11.4.2 Ellex Medical Lasers Business Overview
11.4.3 Ellex Medical Lasers Glaucoma Introduction
11.4.4 Ellex Medical Lasers Revenue in Glaucoma Business (2019-2024)
11.4.5 Ellex Medical Lasers Recent Development
11.5 Abbott Laboratories
11.5.1 Abbott Laboratories Company Detail
11.5.2 Abbott Laboratories Business Overview
11.5.3 Abbott Laboratories Glaucoma Introduction
11.5.4 Abbott Laboratories Revenue in Glaucoma Business (2019-2024)
11.5.5 Abbott Laboratories Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Detail
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Glaucoma Introduction
11.6.4 Johnson & Johnson Revenue in Glaucoma Business (2019-2024)
11.6.5 Johnson & Johnson Recent Development
11.7 Bausch Health(BHC)
11.7.1 Bausch Health(BHC) Company Detail
11.7.2 Bausch Health(BHC) Business Overview
11.7.3 Bausch Health(BHC) Glaucoma Introduction
11.7.4 Bausch Health(BHC) Revenue in Glaucoma Business (2019-2024)
11.7.5 Bausch Health(BHC) Recent Development
11.8 Topcon
11.8.1 Topcon Company Detail
11.8.2 Topcon Business Overview
11.8.3 Topcon Glaucoma Introduction
11.8.4 Topcon Revenue in Glaucoma Business (2019-2024)
11.8.5 Topcon Recent Development
11.9 Lumenis
11.9.1 Lumenis Company Detail
11.9.2 Lumenis Business Overview
11.9.3 Lumenis Glaucoma Introduction
11.9.4 Lumenis Revenue in Glaucoma Business (2019-2024)
11.9.5 Lumenis Recent Development
11.10 Allergan
11.10.1 Allergan Company Detail
11.10.2 Allergan Business Overview
11.10.3 Allergan Glaucoma Introduction
11.10.4 Allergan Revenue in Glaucoma Business (2019-2024)
11.10.5 Allergan Recent Development
11.11 Nidek
11.11.1 Nidek Company Detail
11.11.2 Nidek Business Overview
11.11.3 Nidek Glaucoma Introduction
11.11.4 Nidek Revenue in Glaucoma Business (2019-2024)
11.11.5 Nidek Recent Development
11.12 HAAG-Streit Holding
11.12.1 HAAG-Streit Holding Company Detail
11.12.2 HAAG-Streit Holding Business Overview
11.12.3 HAAG-Streit Holding Glaucoma Introduction
11.12.4 HAAG-Streit Holding Revenue in Glaucoma Business (2019-2024)
11.12.5 HAAG-Streit Holding Recent Development
11.13 Essilor International
11.13.1 Essilor International Company Detail
11.13.2 Essilor International Business Overview
11.13.3 Essilor International Glaucoma Introduction
11.13.4 Essilor International Revenue in Glaucoma Business (2019-2024)
11.13.5 Essilor International Recent Development
11.14 Hoya
11.14.1 Hoya Company Detail
11.14.2 Hoya Business Overview
11.14.3 Hoya Glaucoma Introduction
11.14.4 Hoya Revenue in Glaucoma Business (2019-2024)
11.14.5 Hoya Recent Development
11.15 Ziemer Ophthalmic Systems
11.15.1 Ziemer Ophthalmic Systems Company Detail
11.15.2 Ziemer Ophthalmic Systems Business Overview
11.15.3 Ziemer Ophthalmic Systems Glaucoma Introduction
11.15.4 Ziemer Ophthalmic Systems Revenue in Glaucoma Business (2019-2024)
11.15.5 Ziemer Ophthalmic Systems Recent Development
11.16 Carl Zeiss Meditec
11.16.1 Carl Zeiss Meditec Company Detail
11.16.2 Carl Zeiss Meditec Business Overview
11.16.3 Carl Zeiss Meditec Glaucoma Introduction
11.16.4 Carl Zeiss Meditec Revenue in Glaucoma Business (2019-2024)
11.16.5 Carl Zeiss Meditec Recent Development
11.17 Sonomed Escalon
11.17.1 Sonomed Escalon Company Detail
11.17.2 Sonomed Escalon Business Overview
11.17.3 Sonomed Escalon Glaucoma Introduction
11.17.4 Sonomed Escalon Revenue in Glaucoma Business (2019-2024)
11.17.5 Sonomed Escalon Recent Development
11.18 HumanOptics
11.18.1 HumanOptics Company Detail
11.18.2 HumanOptics Business Overview
11.18.3 HumanOptics Glaucoma Introduction
11.18.4 HumanOptics Revenue in Glaucoma Business (2019-2024)
11.18.5 HumanOptics Recent Development
11.19 PhysIOL
11.19.1 PhysIOL Company Detail
11.19.2 PhysIOL Business Overview
11.19.3 PhysIOL Glaucoma Introduction
11.19.4 PhysIOL Revenue in Glaucoma Business (2019-2024)
11.19.5 PhysIOL Recent Development
11.20 Calhoun Vision Center
11.20.1 Calhoun Vision Center Company Detail
11.20.2 Calhoun Vision Center Business Overview
11.20.3 Calhoun Vision Center Glaucoma Introduction
11.20.4 Calhoun Vision Center Revenue in Glaucoma Business (2019-2024)
11.20.5 Calhoun Vision Center Recent Development
11.21 RISI
11.21.1 RISI Company Detail
11.21.2 RISI Business Overview
11.21.3 RISI Glaucoma Introduction
11.21.4 RISI Revenue in Glaucoma Business (2019-2024)
11.21.5 RISI Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research